Clinical Research Directory
Browse clinical research sites, groups, and studies.
Development of an Accessible Cognitive Behavioral Therapy Digital Therapeutic for Individuals With Long COVID
Sponsor: Toivoa Inc
Summary
This study will evaluate Toivoa-004 as an experimental digital therapeutic for persons with Long COVID suffering from anxiety or depression. This study will evaluate the completion rates of the Toivoa-004 program and survey the user's experience upon completion. Changes in anxiety and depression scores will be monitored during the study.
Key Details
Gender
All
Age Range
22 Years - Any
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2026-07
Completion Date
2026-09
Last Updated
2026-07-20
Healthy Volunteers
No
Conditions
Interventions
Rauha® Digital Therapeutic Platform (Toivoa-004)
A coach-delivered, WCAG 2.2 AA-accessible digital therapeutic targeting anxiety and depression symptom management in adults with clinically documented Long COVID. The platform integrates evidence-based behavioral health content delivered via the Rauha® Coach application.